Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs
Year: 2022
Type: conference-paper
Abstract: Herpes simplex virus type 1 (HSV-1) is a neurotropic virus that infects most humans, attaining 90% prevalence by the sixth decade of life.The virus remains latent in neuronal cell bodies and reactivates due to stress, illness and other unknown factors throughout an individual's life.The disease appears as cold sores, typically seen on the lips or face, with primary infection usually during childhood.In some cases, individuals can develop adverse reactions such as herpes simplex encephalitis (HSE) and recent evidence suggests the involvement of HSV-1 in the etiology of Alzheimer's disease (AD).Sporadic AD is a complex multifactorial neurodegenerative disease with evidence indicating coexisting multi-pathogen and inflammatory etiologies.Citrullination is a post-translational modification (PTM) catalyzed by peptidyl arginine deiminases (PAD) that convert peptidylarginine into peptidylcitrulline, whose dysregulation has been associated with Alzheimer's disease and others neurodegenerative disorders.Against this background, the goal of this project is to characterize the citrullination during infection with HSV-1 in different in vitro models.We demonstrate that HSV-1 triggers PADs expression in Human Foreskin Fibroblasts (HFF), African green monkey kidney cells (VERO) and Human Neuroblastoma Cell Line (SHSY-5) cell lines both at mRNA and protein levels.Furthermore, the overall citrullination profile obtained with the citrulline-specific rhodamine phenylglyoxal (RhPG)-based probe changes consistently at different time points during infection in all tested cell lines.Finally, HSV-1 replication rate is strongly impaired in the presence of Cl-amidine and BB-Cl-amidine, two specific pan-PAD inhibitors, indicating that citrullination is required for HSV-1 replication.These findings could shed light on the role of HSV-1 in the pathogenesis of AD, providing new molecular mechanisms that could be exploited for advanced medical interventions.
Authors: Selina Pasquero, Gloria Griffante(Writing – review & editing), Francesca Gugliesi(Funding acquisition, Writing – original draft, Writing – review & editing), Matteo Biolatti(Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing), Camilla Albano(Writing – review & editing), Greta Bajetto, Valentina Dell'Oste, Paul R Thompson, Sudeshna Sen, Serena Delbue, Silvia Parapini, Maria Dolci, Santo Landolfo, Marco De Andrea
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Compagnia di San Paolo, European Commission, Deutsche Forschungsgemeinschaft, Ministero dell’Istruzione, dell’Università e della Ricerca, Università degli Studi di Torino, Horizon 2020 Framework Programme, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases
Awards: G1613034829, G2156539283, G2465168778, G2991564573, G3329870156, G3726397627, G3764482812, Molecular Genetics of HSV DNA Polymerase Gene, G3919341773, G421462042, Defining the causal association between Human Beta-papillomavirus infection, keratinocyte stem cell expansion and skin cancer development in the immunosuppressed host., G5394206482, G5538140576, G64039306, Persistent and latent viral infections: mechanisms controlling viral reactivation/replication and chronic/degenerative damages., G7599497944, G8897254362, Intrinsic and extrinsic innate immune surveillance against high-risk human papillomavirus infection: molecular mechanisms and novel intervention strategies, Chemical probes to decipher PAD biology
OpenAlex ID: W7218231016
